Figure 4.

vvDD-CXCL11 treatment led to the accumulation of more CD8⁺ T cells in the spleen and mesenteric lymph nodes. Tumor-bearing mice were treated as described in Fig. 2. Mesenteric lymph nodes and spleens were harvested and single cells were stained with APC-α-CD8⁺ Ab day 20 post tumor cell inoculation. The percentage of CD8⁺ T cells in mesenteric lymph nodes and spleens are shown in (A) and (B). Whole splenocytes and absolute splenic CD8⁺ T cells are shown in (C) and (D).